Cost-effectiveness analysis of intranasal live attenuated vaccine (LAIV) versus injectable inactivated influenza vaccine (TIV) for Canadian children and adolescents

• Κύριοι συγγραφείς: Tarride JE (Συγγραφέας), Burke N (Συγγραφέας), Von Keyserlingk C (Συγγραφέας), O'Reilly D (Συγγραφέας), Xie F (Συγγραφέας), Goeree R (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: Dove Medical Press, 2012-10-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Jean-Eric Tarride,1,2 Natasha Burke,1,2 Camilla Von Keyserlingk,1,2 Daria O'Reilly,1,2 Feng Xie,1,2 Ron Goeree1,21Programs for Assessment of Technology in Health (PATH) Research Institute, St Joseph's Healthcare Hamilton, Hamilton, 2Department of Clinical Epidemiology and Biostatisti...